[Cardiovascular safety of DPP-4 inhibitors]
- PMID: 26187593
- DOI: 10.1016/j.semerg.2015.06.003
[Cardiovascular safety of DPP-4 inhibitors]
Comment on
-
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.Lancet. 2015 May 23;385(9982):2067-76. doi: 10.1016/S0140-6736(14)62225-X. Epub 2015 Mar 10. Lancet. 2015. PMID: 25765696 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
